Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

$OMCLPress releaseJul 30, 2026, 4:01 PM ETRead the release

EnlivenHealth, a subsidiary of Omnicell, announced the launch of VaxReach, a proactive vaccine outreach program designed to help pharmacies identify eligible patients and automate engagement to drive in-store traffic. Based on internal modeling, the solution has the potential to increase monthly vaccinations by up to 66% by leveraging automated patient identification and messaging.

Key figures

Us vaccination rate 2025 26
47%
Potential vaccination increase
66%
Americans within 5 miles of pharmacy
90%

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    OMCL: EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination — AI Analysis | Signal8